BSE Live
Feb 26, 16:01Prev. Close
978.55
Open Price
980.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 26, 15:58Prev. Close
978.20
Open Price
983.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
972.15 (2253)
| Balance Sheet of Natco Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 28.15 | 28.04 | 28.04 | 27.64 | 27.17 | |
| Total Share Capital | 28.15 | 28.04 | 28.04 | 27.64 | 27.17 | |
| Reserves and Surplus | 273.28 | 229.86 | 191.16 | 152.50 | 120.51 | |
| Total Reserves and Surplus | 273.28 | 229.86 | 191.16 | 152.50 | 120.51 | |
| Total Shareholders Funds | 301.43 | 257.90 | 219.20 | 180.14 | 147.69 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 64.63 | 65.40 | 43.81 | 31.58 | 38.28 | |
| Deferred Tax Liabilities [Net] | 26.83 | 24.09 | 21.54 | 18.02 | 17.24 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 91.47 | 89.49 | 65.35 | 49.60 | 55.52 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 54.66 | 60.94 | 50.32 | 44.86 | 41.77 | |
| Trade Payables | 70.79 | 24.20 | 43.12 | 39.25 | 38.51 | |
| Other Current Liabilities | 8.79 | 59.64 | 21.63 | 21.96 | 14.47 | |
| Short Term Provisions | 5.61 | 2.52 | 5.00 | 3.85 | 0.00 | |
| Total Current Liabilities | 139.85 | 147.30 | 120.07 | 109.92 | 94.76 | |
| Total Capital And Liabilities | 532.75 | 494.69 | 404.62 | 339.66 | 297.96 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 231.91 | 200.49 | 173.27 | 137.58 | 118.98 | |
| Intangible Assets | 1.29 | 0.66 | 0.45 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 39.60 | 46.96 | 28.57 | 20.14 | 15.46 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 272.80 | 248.11 | 202.29 | 157.72 | 134.44 | |
| Non-Current Investments | 79.23 | 20.80 | 20.80 | 18.46 | 16.62 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 1.15 | 0.00 | 2.24 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 2.54 | |
| Total Non-Current Assets | 352.03 | 268.91 | 224.24 | 176.19 | 155.84 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 65.62 | 64.67 | 55.33 | 49.31 | 42.32 | |
| Trade Receivables | 54.63 | 47.68 | 35.72 | 32.14 | 33.42 | |
| Cash And Cash Equivalents | 3.50 | 20.09 | 19.93 | 24.09 | 27.28 | |
| Short Term Loans And Advances | 56.96 | 93.34 | 69.40 | 57.93 | 39.10 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 180.72 | 225.78 | 180.38 | 163.47 | 142.12 | |
| Total Assets | 532.75 | 494.69 | 404.62 | 339.66 | 297.96 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 30.42 | 36.32 | 44.19 | 17.44 | 17.46 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 7.79 | 10.52 | 15.01 | 13.77 | 8.90 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 10.95 | 12.36 | 4.33 | 7.51 | 3.57 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 2.01 | 3.15 | 27.82 | 7.95 | 19.13 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 0.11 | 0.07 | 0.08 | 0.08 | 0.08 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 96.44 | 103.26 | 92.96 | 84.83 | 80.58 | |
| Other Earnings | 1.80 | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | 0.00 | 0.01 | 1.85 | 0.01 | |
| Non-Current Investments Unquoted Book Value | 79.23 | 20.77 | 20.77 | 16.61 | 16.61 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
16.02.2026
Natco Pharma shares rise over 11% after firm receives approval to launch Semaglutide in India
16.02.2026
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y